| Literature DB >> 25590297 |
Dae-Young Lee1, Byeong-Ju Cha2, Young-Seob Lee3, Geum-Soog Kim4, Hyung-Jun Noh5, Seung-Yu Kim6, Hee Cheol Kang7, Jin Hee Kim8, Nam-In Baek9.
Abstract
Three minor ginsenosides, namely, ginsenoside Rh6 (1), vina-ginsenoside R4 (2) and vina-ginsenoside R13 (3), were isolated from the leaves of hydroponic Panax ginseng. The chemical structures were determined based on spectroscopic methods, including fast atom bombardment mass spectroscopy (FAB-MS), 1D-nuclear magnetic resonance (NMR), 2D-NMR, and, infrared (IR) spectroscopy. The melanogenic inhibitory activity of compounds 1, 2 and 3 was 23.9%, 27.8% and 35.2%, respectively, at a concentration of 80 µM. Likewise, the three compounds showed inhibitory activity on body pigmentation on a zebrafish model, which is commonly used as a model for biomedical or cosmetic research. These results from in vitro and in vivo systems suggest that the three aforementioned compounds isolated from Panax ginseng may have potential as new skin whitening compounds.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25590297 PMCID: PMC4307327 DOI: 10.3390/ijms16011677
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Chemical structures of compounds 1–3 isolated from the leaves of P. ginseng.
Figure 2Effects of compounds 1, 2 and 3 on melanogenesis in melan-a cells. Cells were cultured with 0–80 µM of the compounds for three days. The inhibition of melanin synthesis was measured with a triplicate experiment. Each value is expressed as the mean ± SD of the triplicate determinations. * p < 0.05, ** p < 0.01 versus the control group. (Control: vehicle control (0.1% DMSO), Compound 1: ginsenoside Rh6; Compound 2: vina-ginsenoside R4; Compound 3: vina-ginsenoside R13).
Figure 3Effects of compounds 1, 2 and 3 on melanogenesis in zebrafish. Synchronized embryos were treated with melanogenic inhibitors at the indicated concentrations. The compounds were dissolved in 0.1% DMSO then added to the embryo medium. The effects on the pigmentation of zebra fish were observed under a stereomicroscope ((A) vehicle controls; (B) (positive control): 100 of µM 1-phenyl-2-thiourea (PTU); (C) (compound 1): 40 µM of ginsenoside Rh6; (D) (compound 2): 40 µM of vina-ginsenoside R4; (E) (compound 3): 40 µM of vina-ginsenoside R13).
1H-NMR (400 MHz) and 13C-NMR (100 MHz) spectra of compounds 1–3 (in pyridine-d5, δ in ppm, J in Hz) a.
| Carbon | Compound 1 | Compound 2 | Compound 3 | |||
|---|---|---|---|---|---|---|
| No. | δH | δC | δH | δC | δH | δC |
| 1 | 1.71, 1.00 | 39.3 | 1.55, 0.76 | 39.1 | 1.51, 0.72 | 39.1 |
| 2 | 1.86, 1.84 | 28.0 | 2.23, 1.80 | 26.5 | 2.17, 1.80 | 26.6 |
| 3 | 3.49 (1H, dd, | 78.4 | 3.33 (1H, dd, | 89.4 | 3.25 (1H, dd, | 88.9 |
| 4 | - | 40.3 | - | 40.5 | - | 39.6 |
| 5 | 1.20 (1H, d, | 61.7 | 1.06 (1H, d, | 61.6 | 0.67 (1H, d,
| 56.3 |
| 6 | 4.39 (1H, m) | 67.7 | 4.31 (1H, m) | 67.4 | 1.50, 1.30 | 18.3 |
| 7 | 1.90, 1.87 | 47.4 | 1.85, 1.81 | 47.4 | 1.44, 1.18 | 35.0 |
| 8 | - | 41.2 | - | 41.0 | - | 39.9 |
| 9 | 1.51 | 49.8 | 1.41 | 49.7 | 1.35 | 50.0 |
| 10 | - | 39.3 | - | 38.7 | - | 36.8 |
| 11 | 2.09, 1.57 | 30.6 | 1.97, 1.40 | 30.7 | 1.92, 1.33 | 30.8 |
| 12 | 4.08 (1H, m) | 70.4 | 4.05 (1H, m) | 70.1 | 3.89 (1H, m) | 70.4 |
| 13 | 1.90 (1H, m) | 49.1 | 1.92 | 49.0 | 2.02 | 49.1 |
| 14 | - | 51.3 | - | 51.2 | - | 51.4 |
| 15 | 1.44, 0.94 | 30.9 | 1.50, 0.97 | 30.7 | 1.53, 0.96 | 30.8 |
| 16 | 1.79, 1.41 | 26.4 | 1.79, 1.28 | 26.5 | 1.80, 1.45 | 26.6 |
| 17 | 2.39 (1H, m) | 52.2 | 2.48 (1H, m) | 51.6 | 2.41 (1H, m) | 52.6 |
| 18 | 1.13 (3H, s) | 17.5 | 1.02 (3H, s) | 17.4 | 0.86 (3H, s) | 17.0 |
| 19 | 1.03 (3H, s) | 17.4 | 0.88 (3H, s) | 17.2 | 0.79 (3H, s) | 16.2 |
| 20 | - | 83.1 | - | 83.6 | - | 83.2 |
| 21 | 1.55 (3H, s) | 23.2 | 1.57 (3H, s) | 22.3 | 1.58 (3H, s) | 22.7 |
| 22 | 2.70 (1H, dd, | 39.6 | 2.31 (1H, br d, | 35.9 | 2.93 (1H, dd, | 33.7 |
| 23 | 6.15, (1H, ddd,
| 126.4 | 2.47, 2.22 | 23.1 | 2.18, 2.06 | 27.0 |
| 24 | 6.03 (1H, d, | 138.0 | 5.22 (1H, dd, | 125.8 | 3.71 (1H, br d, | 79.7 |
| 25 | - | 81.2 | - | 130.8 | - | 72.7 |
| 26 | 1.56 (3H, s) | 25.7 | 1.57 (3H, s) | 25.6 | 1.52 (3H, s) | 26.4 |
| 27 | 1.55 (3H, s) | 25.3. | 1.57 (3H, s) | 17.6 | 1.51 (3H, s) | 25.8 |
| 28 | 1.94 (3H, s) | 31.9 | 1.94 (3H, s) | 31.2 | 1.27 (3H, s) | 28.0 |
| 29 | 1.41 (3H, s) | 16.4 | 1.46 (3H, s) | 16.7 | 1.09 (3H, s) | 16.5 |
| 30 | 0.89 (3H, s) | 17.1 | 0.94 (3H, s) | 17.3 | 0.89 (3H, s) | 15.7 |
| 3- | - | - | 4.90 (1H, d, | 105.1 | 4.89 (1H, d, | 104.9 |
| 2' | - | - | 4.25 (1H, overlapped) | 83.6 | 4.17 (1H, overlapped) | 83.4 |
| 3' | - | - | 4.28–4.10 (overlapped) | 77.9 | 3.95 (1H, overlapped) | 78.6 |
| 4' | - | - | 4.24–4.00 (overlapped) | 71.5 | 4.32 (1H, overlapped) | 71.7 |
| 5' | - | - | 3.87–3.86 (overlapped) | 78.1 | 4.01–3.84 (overlapped) | 78.2 |
| 6' | - | - | 4.53–4.11 (overlapped) | 62.8 | 4.60–4.10 (overlapped) | 62.7 |
| 2'-O-glc-1'' | - | - | 5.34 (1H, d, | 105.7 | 5.33 (1H, d, | 105.8 |
| 2'' | - | - | 4.05 (1H, overlapped) | 76.8 | 4.10 (1H, overlapped) | 76.9 |
| 3'' | - | - | 4.28–4.10 (overlapped) | 79.0 | 4.20 (1H, overlapped) | 78.6 |
| 4'' | - | - | 4.24–4.00 (overlapped) | 71.6 | 4.08 (1H, overlapped) | 71.6 |
| 5'' | - | - | 3.87–3.86 (overlapped) | 78.3 | 4.01–3.84 (overlapped) | 77.8 |
| 6'' | - | - | 4.53–4.11 (overlapped) | 62.8 | 4.60–4.10 (overlapped) | 62.8 |
| 20- | 5.17 (1H, d, | 98.2 | 5.12 (1H, d, | 98.1 | 5.20 (1H, d, | 98.2 |
| 2''' | 3.98 (1H, dd, | 75.2 | 3.93 (1H, dd, | 75.0 | 3.94 (1H, overlapped) | 75.3 |
| 3''' | 4.16 (1H, dd, | 78.7 | 4.28–4.10 (overlapped) | 78.0 | 4.21 (1H, overlapped) | 78.0 |
| 4''' | 4.11 (1H, dd, | 71.6 | 4.24–4.00 (overlapped) | 71.7 | 3.95 (1H, overlapped) | 71.6 |
| 5''' | 3.94 (1H, ddd, | 78.1 | 3.87–3.86 (overlapped) | 77.9 | 4.01–3.84 (overlapped) | 77.9 |
| 6''' | 4.45 (1H, dd, | 62.9 | 4.53–4.11 (overlapped) | 62.8 | 4.60–4.10 (overlapped) | 63.0 |
a Assignments were confirmed by DEPT, 1H-1H COSY, HSQC, and HMBC.